Search

Author/Creator Backes, Floor J

1. 2022-RA-324-ESGO Phase 2 results from the LIO-1 STUDY (NCT04042116; ENGOT-GYN3/AGO/LIO): efficacy and safety of lucitanib + nivolumab in patients with advanced gynaecological malignancies. (20th October 2022)

Authors:
Concin, Nicole; Patel, Manish R; Makker, Vicky; Oaknin, Ana; Pignata, Sandro; Backes, Floor J; González-Martín, Antonio; Eskander, Ramez N; Pothuri, Bhavana; Richardson, Debra L; Secord, Angeles Alvarez; van Nieuwenhuysen, Els; Liu, Joyce F; Musa, Fernanda; Penson, Richard T; Wride, Kenton; Dusek...
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A185
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer. Issue 3 (14th March 2022)

Authors:
Lheureux, Stephanie; Matei, Daniela E; Konstantinopoulos, Panagiotis A; Wang, Ben X; Gadalla, Ramy; Block, Matthew S; Jewell, Andrea; Gaillard, Stephanie L; McHale, Michael; McCourt, Carolyn; Temkin, Sarah; Girda, Eugenia; Backes, Floor J; Werner, Theresa L; Duska, Linda; Kehoe, Siobhan; Colombo,...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 3(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗